Bayer AG, which bought Monsanto last summer, said Monday that it was making scientific studies available for public scrutiny in an effort to counter growing concerns about the safety of Monsanto’s flagship glyphosate-based herbicide products. “Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policymakers and businesses,  Liam Condon, … Bayer Makes Bid for “Trust” Amid Third Monsanto Cancer Trial